Transcription Factor-DNA Interactions at the Substance P Enhancer, ECR1

John Barrow, Alasdair MacKenzie

Research output: Contribution to conferenceAbstract

Abstract

Controlling the expression of the TAC1 gene is crucial to controlling fear, anxiety and depression. TAC1 codes for the protein Substance P; a small neuropeptide that is involved in modulating anxiety and depression states. Mouse knockout studies were the Substance P receptor (NK1) function is lost, show animals with reduced fear and anxiety responses and more aggression than wild type mice. High levels of Substance P and NK1 receptor are also present in the amygdala, and exposing rodents to stress increases the expression of TAC1 markedly within the amygdala compared to wild type animals. Despite an understanding of the role of Substance P in the brain, almost nothing is understood about the way this gene is controlled both in a tissue specific manner and in response to various stimuli, such as stress or pain. With this in mind, our lab has identified a remote enhancer to the TAC1 gene, termed ECR1. This enhancer is able to drive expression of a LacZ reporter construct in transgenic mice, and is only active in the amygdalaloidal regions of the brain. We have identified numerous evolutionarily conserved transcription factor binding sequences within ECR1 that may play a role in the expression of the TAC1 gene. Analysis of ECR1 DNA sequences from many species shows an almost complete conservation of the sequence throughout vertebrate evolution; with ECR1 being conserved all the way back to chicken. This equates to ECR1 being conserved across 300 million years of evolution. It is believed that the transcription factors controlling ECR1 activity are in turn controlled by signal transduction mechanisms that may involve many pathways such as PKA, PKC, and MAPKs. Using a unique combination of bioinformatics, transgenics, organotypic culture and protein-DNA interaction techniques we have begun to dissect the mechanisms that underlie ECR1 activity. In understanding these mechanisms it is hoped that new and potentially clinical targets for novel therapies to disorders such as anxiety and depression can be identified.
Original languageEnglish
Publication statusPublished - 6 Jun 2006
EventMechanisms Underlying Emerging Themes in Neurobiology - University College Cork, Cork, Ireland
Duration: 6 Jun 20067 Jun 2006

Conference

ConferenceMechanisms Underlying Emerging Themes in Neurobiology
CountryIreland
CityCork
Period6/06/067/06/06

Fingerprint

Substance P
Transcription Factors
Anxiety
Neurokinin-1 Receptors
DNA
Depression
Amygdala
Fear
Gene Expression
Wild Animals
Brain
Computational Biology
Neuropeptides
Aggression
DNA Sequence Analysis
Knockout Mice
Transgenic Mice
Genes
Vertebrates
Chickens

Cite this

Barrow, J., & MacKenzie, A. (2006). Transcription Factor-DNA Interactions at the Substance P Enhancer, ECR1. Abstract from Mechanisms Underlying Emerging Themes in Neurobiology, Cork, Ireland.

Transcription Factor-DNA Interactions at the Substance P Enhancer, ECR1. / Barrow, John; MacKenzie, Alasdair.

2006. Abstract from Mechanisms Underlying Emerging Themes in Neurobiology, Cork, Ireland.

Research output: Contribution to conferenceAbstract

Barrow, J & MacKenzie, A 2006, 'Transcription Factor-DNA Interactions at the Substance P Enhancer, ECR1' Mechanisms Underlying Emerging Themes in Neurobiology, Cork, Ireland, 6/06/06 - 7/06/06, .
Barrow J, MacKenzie A. Transcription Factor-DNA Interactions at the Substance P Enhancer, ECR1. 2006. Abstract from Mechanisms Underlying Emerging Themes in Neurobiology, Cork, Ireland.
Barrow, John ; MacKenzie, Alasdair. / Transcription Factor-DNA Interactions at the Substance P Enhancer, ECR1. Abstract from Mechanisms Underlying Emerging Themes in Neurobiology, Cork, Ireland.
@conference{8046cee4349f4e50892348931ffad873,
title = "Transcription Factor-DNA Interactions at the Substance P Enhancer, ECR1",
abstract = "Controlling the expression of the TAC1 gene is crucial to controlling fear, anxiety and depression. TAC1 codes for the protein Substance P; a small neuropeptide that is involved in modulating anxiety and depression states. Mouse knockout studies were the Substance P receptor (NK1) function is lost, show animals with reduced fear and anxiety responses and more aggression than wild type mice. High levels of Substance P and NK1 receptor are also present in the amygdala, and exposing rodents to stress increases the expression of TAC1 markedly within the amygdala compared to wild type animals. Despite an understanding of the role of Substance P in the brain, almost nothing is understood about the way this gene is controlled both in a tissue specific manner and in response to various stimuli, such as stress or pain. With this in mind, our lab has identified a remote enhancer to the TAC1 gene, termed ECR1. This enhancer is able to drive expression of a LacZ reporter construct in transgenic mice, and is only active in the amygdalaloidal regions of the brain. We have identified numerous evolutionarily conserved transcription factor binding sequences within ECR1 that may play a role in the expression of the TAC1 gene. Analysis of ECR1 DNA sequences from many species shows an almost complete conservation of the sequence throughout vertebrate evolution; with ECR1 being conserved all the way back to chicken. This equates to ECR1 being conserved across 300 million years of evolution. It is believed that the transcription factors controlling ECR1 activity are in turn controlled by signal transduction mechanisms that may involve many pathways such as PKA, PKC, and MAPKs. Using a unique combination of bioinformatics, transgenics, organotypic culture and protein-DNA interaction techniques we have begun to dissect the mechanisms that underlie ECR1 activity. In understanding these mechanisms it is hoped that new and potentially clinical targets for novel therapies to disorders such as anxiety and depression can be identified.",
author = "John Barrow and Alasdair MacKenzie",
year = "2006",
month = "6",
day = "6",
language = "English",
note = "Mechanisms Underlying Emerging Themes in Neurobiology ; Conference date: 06-06-2006 Through 07-06-2006",

}

TY - CONF

T1 - Transcription Factor-DNA Interactions at the Substance P Enhancer, ECR1

AU - Barrow, John

AU - MacKenzie, Alasdair

PY - 2006/6/6

Y1 - 2006/6/6

N2 - Controlling the expression of the TAC1 gene is crucial to controlling fear, anxiety and depression. TAC1 codes for the protein Substance P; a small neuropeptide that is involved in modulating anxiety and depression states. Mouse knockout studies were the Substance P receptor (NK1) function is lost, show animals with reduced fear and anxiety responses and more aggression than wild type mice. High levels of Substance P and NK1 receptor are also present in the amygdala, and exposing rodents to stress increases the expression of TAC1 markedly within the amygdala compared to wild type animals. Despite an understanding of the role of Substance P in the brain, almost nothing is understood about the way this gene is controlled both in a tissue specific manner and in response to various stimuli, such as stress or pain. With this in mind, our lab has identified a remote enhancer to the TAC1 gene, termed ECR1. This enhancer is able to drive expression of a LacZ reporter construct in transgenic mice, and is only active in the amygdalaloidal regions of the brain. We have identified numerous evolutionarily conserved transcription factor binding sequences within ECR1 that may play a role in the expression of the TAC1 gene. Analysis of ECR1 DNA sequences from many species shows an almost complete conservation of the sequence throughout vertebrate evolution; with ECR1 being conserved all the way back to chicken. This equates to ECR1 being conserved across 300 million years of evolution. It is believed that the transcription factors controlling ECR1 activity are in turn controlled by signal transduction mechanisms that may involve many pathways such as PKA, PKC, and MAPKs. Using a unique combination of bioinformatics, transgenics, organotypic culture and protein-DNA interaction techniques we have begun to dissect the mechanisms that underlie ECR1 activity. In understanding these mechanisms it is hoped that new and potentially clinical targets for novel therapies to disorders such as anxiety and depression can be identified.

AB - Controlling the expression of the TAC1 gene is crucial to controlling fear, anxiety and depression. TAC1 codes for the protein Substance P; a small neuropeptide that is involved in modulating anxiety and depression states. Mouse knockout studies were the Substance P receptor (NK1) function is lost, show animals with reduced fear and anxiety responses and more aggression than wild type mice. High levels of Substance P and NK1 receptor are also present in the amygdala, and exposing rodents to stress increases the expression of TAC1 markedly within the amygdala compared to wild type animals. Despite an understanding of the role of Substance P in the brain, almost nothing is understood about the way this gene is controlled both in a tissue specific manner and in response to various stimuli, such as stress or pain. With this in mind, our lab has identified a remote enhancer to the TAC1 gene, termed ECR1. This enhancer is able to drive expression of a LacZ reporter construct in transgenic mice, and is only active in the amygdalaloidal regions of the brain. We have identified numerous evolutionarily conserved transcription factor binding sequences within ECR1 that may play a role in the expression of the TAC1 gene. Analysis of ECR1 DNA sequences from many species shows an almost complete conservation of the sequence throughout vertebrate evolution; with ECR1 being conserved all the way back to chicken. This equates to ECR1 being conserved across 300 million years of evolution. It is believed that the transcription factors controlling ECR1 activity are in turn controlled by signal transduction mechanisms that may involve many pathways such as PKA, PKC, and MAPKs. Using a unique combination of bioinformatics, transgenics, organotypic culture and protein-DNA interaction techniques we have begun to dissect the mechanisms that underlie ECR1 activity. In understanding these mechanisms it is hoped that new and potentially clinical targets for novel therapies to disorders such as anxiety and depression can be identified.

M3 - Abstract

ER -